Biotech

All Articles

Former Seagen chief executive officer introduces new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer in 2015 for a ...

Ironwood produces more purpose $1B GI drug with new subgroup data

.On the heels of a phase 3 win that stopped working to thrill entrepreneurs, Ironwood Pharmaceutical...

Novartis inks $150M offer for autoimmune molecular adhesive

.Don't stop Monte Rosa Rehabs now. The Boston-based biotech is having a ball after authorizing a cop...

Jade takes officer group with Chinook veterinarians-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings an...

Septerna goes public with upsized offering of $288M

.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...

AbbVie brings in Richter wealthier, spending $25M to make up discovery pact

.AbbVie has actually gone back to the resource of its antipsychotic giant Vraylar looking for anothe...

GenSight gets in final weeks of cash path as revenue stream edges out of reach

.GenSight Biologics is weeks off of lacking loan. Once more. The biotech just possesses enough money...

AZ licenses discarded uncommon condition drug to Monopar Therapies

.Monopar Rehabs is recouping a drug coming from the scrap heap of AstraZeneca's unusual disease pipe...

Arcus' brand new HIF-2a information in kidney cancer cells mention prospective advantage over Merck's Welireg, professionals point out

.With new data out on Arcus Biosciences' experimental HIF-2a prevention, one team of professionals f...

Roche bets approximately $1B to grow Dyno genetics therapy shipment deal

.After forming a gene therapy alliance with Dyno Rehabs in 2020, Roche is back for even more.In a br...